West, A C
Martin, B P
Andrews, D A
Hogg, S J
Banerjee, A
Grigoriadis, G
Johnstone, R W
Shortt, J
Article History
Received: 1 February 2016
Revised: 29 February 2016
Accepted: 29 February 2016
First Online: 4 April 2016
Competing interests
: LCL-161 was provided by Novartis. RJ has received honoraria and attended advisory boards for Novartis. JS has received travel sponsorship and attended advisory boards for Novartis. The other authors have no relevant conflicts of interest to declare.